Everyday Health Reports Third Quarter 2015 Financial Results

Go back to Everyday Health Reports Third Quarter 2015 Financial Results

Everyday Health (EVDY) Says Sales Execution Problems Affected Consumer Segment; Leerink Partners Reiterates Outperform

November 11, 2015 6:51 AM EST

Leerink Partners maintained an Outperform rating on Everyday Health (NYSE: EVDY), and cut the price target to $15.00 (from $27.00), following the company's 3Q earnings report. Everyday Health reported 3Q15 revenue of $54.3m, $2.5m or 4% below Street expectations. Management lowered guidance for 2015 by 5% from $240m... More

Everyday Health (EVDY) Misses Q3 EPS by 1c; Announces Launch of TVRx

November 10, 2015 4:10 PM EST

Everyday Health (NYSE: EVDY) reported Q3 EPS of $0.07, $0.01 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $54.3 million versus the consensus estimate of $56.87 million.

Guidance:

Everyday Health sees Q4 2015 revenue of $75-80 million, versus the consensus of $87.3 million.

Everyday Health sees FY2015 revenue of $225-230 million, versus the consensus of $240.1 million.

Additional News:

Everyday Health and Videology, a leading software provider for converged TV and video advertising, announced the launch of TVRx, a solution for pharmaceutical and health-oriented marketers to target... More